Annual Retained Earnings
-$129.48 M
-$101.72 M-366.38%
December 31, 2021
Summary
- As of February 7, 2025, STAB annual retained earnings is -$129.48 million, with the most recent change of -$101.72 million (-366.38%) on December 31, 2021.
- During the last 3 years, STAB annual retained earnings has fallen by -$113.94 million (-733.35%).
- STAB annual retained earnings is now -733.35% below its all-time high of -$15.54 million, reached on December 31, 2019.
Performance
STAB Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$144.08 M
-$3.35 M-2.38%
September 30, 2022
Summary
- As of February 7, 2025, STAB quarterly retained earnings is -$144.08 million, with the most recent change of -$3.35 million (-2.38%) on September 30, 2022.
- Over the past year, STAB quarterly retained earnings has dropped by -$91.82 million (-175.71%).
- STAB quarterly retained earnings is now -418.95% below its all-time high of -$27.76 million, reached on December 31, 2020.
Performance
STAB Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
STAB Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -366.4% | -175.7% |
| 3 y3 years | -733.4% | - |
| 5 y5 years | -733.4% | - |
STAB Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -11.3% | at low |
| 5 y | 5-year | -733.4% | at low | -418.9% | at low |
| alltime | all time | -733.4% | at low | -418.9% | at low |
Statera Biopharma Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -$144.08 M(+2.4%) |
| Jun 2022 | - | -$140.73 M(+2.5%) |
| Mar 2022 | - | -$137.24 M(+6.0%) |
| Dec 2021 | -$129.48 M | -$129.48 M(+147.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | -$52.26 M(+32.2%) |
| Jun 2021 | - | -$39.52 M(+20.1%) |
| Mar 2021 | - | -$32.92 M(+18.6%) |
| Dec 2020 | -$27.76 M(+78.7%) | -$27.76 M |
| Dec 2019 | -$15.54 M | - |
FAQ
- What is Statera Biopharma annual retained earnings?
- What is the all time high annual retained earnings for Statera Biopharma?
- What is Statera Biopharma annual retained earnings year-on-year change?
- What is Statera Biopharma quarterly retained earnings?
- What is the all time high quarterly retained earnings for Statera Biopharma?
- What is Statera Biopharma quarterly retained earnings year-on-year change?
What is Statera Biopharma annual retained earnings?
The current annual retained earnings of STAB is -$129.48 M
What is the all time high annual retained earnings for Statera Biopharma?
Statera Biopharma all-time high annual retained earnings is -$15.54 M
What is Statera Biopharma annual retained earnings year-on-year change?
Over the past year, STAB annual retained earnings has changed by -$101.72 M (-366.38%)
What is Statera Biopharma quarterly retained earnings?
The current quarterly retained earnings of STAB is -$144.08 M
What is the all time high quarterly retained earnings for Statera Biopharma?
Statera Biopharma all-time high quarterly retained earnings is -$27.76 M
What is Statera Biopharma quarterly retained earnings year-on-year change?
Over the past year, STAB quarterly retained earnings has changed by -$91.82 M (-175.71%)